IPCIQ (IntelliPharmaCeutics International) Shiller PE Ratio: (As of Aug. 30, 2026)

IntelliPharmaCeutics International  (OTCPK:IPCIQ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.

Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.

IntelliPharmaCeutics International Shiller PE Ratio Related Terms

The historical data trend for IntelliPharmaCeutics International's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IntelliPharmaCeutics International Shiller PE Ratio Chart

IntelliPharmaCeutics International Annual Data
	Trend	Nov13	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22
Shiller PE Ratio		Get a 7-Day Free Trial					0.00	0.00	0.00	0.00	0.00

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Shiller PE Ratio	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

IPCIQ vs CHRO, KTTA, FRTX: Shiller PE Ratio Comparison

For the Biotechnology subindustry, IntelliPharmaCeutics International's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IntelliPharmaCeutics International Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IntelliPharmaCeutics International's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IntelliPharmaCeutics International's Shiller PE Ratio falls into.

IntelliPharmaCeutics International Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

IntelliPharmaCeutics International's E10 for the quarter that ended in Aug. 2023 is calculated as:

For example, IntelliPharmaCeutics International's adjusted earnings per share data for the three months ended in Aug. 2023 was:

Current CPI (Aug. 2023) = 125.3885.

IntelliPharmaCeutics International Quarterly Data

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

IntelliPharmaCeutics International Business Description